Treatment success rate: XDR-TB cases in Lower-middle income (World Bank)
Lower-middle income (World Bank): Treatment success rate: XDR-TB cases was 73 in 2022. ▲ Rising
Latest (2022)
73
Change on year
up 4.3%
Rank
2nd
of 11 groups
All-time high
73
in 2022
All-time low
10
in 2008
Years of data
15
2008–2022
Treatment success rate: XDR-TB cases in Lower-middle income (World Bank), 2008–2022
Source: World Health Organization, Global Health Observatory.
Analysis
In 2022, treatment success rate: xdr-tb cases in Lower-middle income (World Bank) stood at 73. That is the highest value across all 15 years on record.
Compared with earlier readings it is up 4.3% on the previous year and up 151.7% over ten years.
Over the whole period, treatment success rate: xdr-tb cases in Lower-middle income (World Bank) peaked at 73 in 2022 and was at its lowest, 10, in 2008.
The long-run direction has been consistently rising across the 15 years of available data.
Treatment success rate: XDR-TB cases in Lower-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 10 | — |
| 2009 | 14 | +40.0% |
| 2010 | 17 | +21.4% |
| 2011 | 33 | +94.1% |
| 2012 | 29 | -12.1% |
| 2013 | 33 | +13.8% |
| 2014 | 30 | -9.1% |
| 2015 | 28 | -6.7% |
| 2016 | 33 | +17.9% |
| 2017 | 42 | +27.3% |
| 2018 | 52 | +23.8% |
| 2019 | 60 | +15.4% |
| 2020 | 65 | +8.3% |
| 2021 | 70 | +7.7% |
| 2022 | 73 | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12 | 10 | 14 | 2 |
| 2010s | 35.7 | 17 | 60 | 10 |
| 2020s | 69.33 | 65 | 73 | 3 |
Countries ranked near Lower-middle income (World Bank)
- 1 Australia 100 compare
- 1 Nicaragua 100 compare
- 1 United States of America 100 compare
- 1 Equatorial Guinea 100 compare
- 1 Tanzania, United Republic of 100 compare
- 1 Morocco 100 compare
- 1 Hong Kong, China 100 compare
- 1 Papua New Guinea 100 compare
- 1 Niger 100 compare
- 1 Portugal 100 compare
- 1 Israel 100 compare
- 1 Botswana 100 compare
- 1 Congo, Democratic Republic of the 100 compare
- 1 Cameroon 100 compare
- 1 Panama 100 compare
- 1 Somalia 100 compare
- 1 Canada 100 compare
More health data for Lower-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 7,080 (2025)
- Total tetanus - number of reported cases, gaps filled 16,092 (2025)
- Diphtheria - number of reported cases, gaps filled 20,601 (2025)
- Measles - number of reported cases, gaps filled 97,321 (2025)
- Measles - number of reported cases, annual growth rate -8.83 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -40.79 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 117.14 % change on previous year (2025)
- Diphtheria - number of reported cases 20,601 (2025)
- Total tetanus - number of reported cases 16,092 (2025)
- Pertussis - number of reported cases 7,080 (2025)
Frequently asked questions
- What is treatment success rate: xdr-tb cases in Lower-middle income (World Bank)?
- Treatment success rate: xdr-tb cases in Lower-middle income (World Bank) was 73 in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: xdr-tb cases recorded in Lower-middle income (World Bank)?
- The highest recorded value was 73 in 2022.
- What is the lowest treatment success rate: xdr-tb cases recorded in Lower-middle income (World Bank)?
- The lowest recorded value was 10 in 2008.
- How does Lower-middle income (World Bank) rank for treatment success rate: xdr-tb cases?
- Lower-middle income (World Bank) ranks 2nd out of 11 groups with data for 2022.
- Is treatment success rate: xdr-tb cases rising or falling in Lower-middle income (World Bank)?
- Over the last ten years it is up 151.7%. The long-run trend across the full record is rising.
- Where does this Lower-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: XDR-TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).